Long-term CPAP Use Linked With Improved Sleepiness, Depressive Symptoms in Patients With OSA

March 4th 2021, 8:00pm


Patients with obstructive sleep apnea (OSA) exhibited improvements in sleepiness, depressive, and anxiety symptoms after 3 years of continuous positive airway pressure therapy (CPAP) use, although higher adherence to CPAP was linked with weight gain.

Irregular Sleep Schedule Linked With Depression, Worse Mood

March 2nd 2021, 6:45pm


An irregular sleeping schedule is associated with a greater risk of depression in the long term, with consequences similar to results seen among persons who sleep fewer hours overall or stay up late most nights.

Telephone CBT-I Shown to Improve Sleep, Fatigue in Older Adults With Osteoarthritis Pain

February 26th 2021, 6:52pm


Patients with osteoarthritis-related pain were shown to benefit from cognitive behavioral therapy for insomnia (CBT-I) via telephone, in which the treatment significantly improved sleep and fatigue after 12 months, with pain temporarily relieved as well.

OSA Linked With Increase in Heart Rhythm Disorder Incidence, Adverse Outcomes

February 22nd 2021, 8:30pm


Elderly patients who recently had a heart attack and fit the criteria for obstructive sleep apnea were shown to be at greater risk for heart rhythm disorders, such as arrhythmia and coronary artery disease, as well as for major adverse cardiovascular and cerebrovascular events.

Five Hours or Less of Sleep Associated With Increased Risk of Dementia, Death in Older Adults

February 19th 2021, 4:00pm


Older adults who reported getting 5 hours or less of sleep per night exhibited a more than 2-fold increased risk of dementia than those who reported 7 to 8 hours of sleep, with sleep disturbance and deficiency additionally linked with overall risk of death.

Jazz Pharmaceuticals Submits Supplemental NDA for Xywav in Idiopathic Hypersomnia

February 16th 2021, 6:52pm


Based on positive phase 3 results in adults with idiopathic hypersomnia, Jazz Pharmaceuticals submitted a supplemental new drug application (NDA) to the FDA for Xywav (calcium, magnesium, potassium, and sodium oxybates) oral solution.

Polysomnography May Help Prevent Unnecessary Surgery in Children With Sleep-Disordered Breathing

February 13th 2021, 2:30pm


Nearly 45% of children who underwent diagnostic polysomnography (PSG) for obstructive sleep-disordered breathing were found to have normal sleep studies, warranting greater consideration of PSG to manage adverse sleep symptoms in children and potentially prevent unnecessary surgery.

FDA Clears First Daytime Treatment Device for Obstructive Sleep Apnea

February 10th 2021, 7:45pm


The FDA approved a prescription tongue muscle stimulation device that claims to reduce mild sleep apnea and snoring in patients with obstructive sleep apnea.

Job Stressors Linked With Mental Health Issues, Sleep Difficulty in Nurses Amid Pandemic

February 8th 2021, 2:00pm


Occupational stressors in nurses working during the peak of the coronavirus disease 2019 pandemic in China were found to be significantly correlated with mental health and sleep difficulty.

Housing Insecurity Linked With Lower Sleep Duration, Quality

February 1st 2021, 8:42pm


Welfare recipients who were unable to meet their rent or mortgage payments were more likely to have impaired sleep duration and sleep quality, with those forced to move exhibiting more severe impairment.